Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2024 Earnings Call Transcript
Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2024 Earnings Call Transcript February 13, 2025Blueprint Medicines Corporation misses on earnings expectations.
Blueprint Medicines Corp (BPMC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 1,185,000 | $103,355,700 | 1.46% | |
| 2. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 1,096,899 | $95,671,531 | +43% | 3.64% |
| 3. | Alkeon Capital Management Panayotis Takis Sparaggis | 800,628 | $69,830,775 | +12% | 0.14% |
| 4. | Millennium Management Israel Englander | 737,364 | $64,312,888 | +20% | 0.03% |
| 5. | Citadel Investment Group Ken Griffin | 649,958 | $56,689,336 | +735% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $43.98 | 1,100 | 92,281 | 2022-11-03 | Filing | ||
| $82.66 | 10 | 5,822 | 2021-07-13 | Filing | ||
| $59.98 | 5,000 | 10,812 | 2022-03-03 | Filing | ||
| $18.00 | 125,000 | Large Shareholder, Other | 2,500,711 | 2015-05-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $110.24 | 1,446 | 149,378 | 2025-01-21 | Filing | ||
| $111.81 | 121 | 67,109 | 2025-01-21 | Filing | ||
| $110.78 | 808 | 67,230 | 2025-01-21 | Filing | ||
| $110.00 | 816 | 68,038 | 2025-01-21 | Filing | ||
| $108.99 | 529 | 68,854 | 2025-01-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,869,327 | $599,142,701 | 0.01% | |
| 2. | 6,774,884 | $590,905,383 | 0.01% | |
| 3. | 4,281,364 | $373,420,566 | 0.06% | |
| 4. | 2,500,207 | $218,068,055 | 0% | |
| 5. | 2,247,679 | $196,042,519 | 0.01% |
News See All
Why These 15 Stocks Are Skyrocketing in 2025
Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward tech innovation.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q3 2024 Earnings Call Transcript
Operator: Good morning. My name is Nadia, and I'll be your conference operator today.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q2 2024 Earnings Call Transcript
Blueprint Medicines Corporation (NASDAQ:BPMC) Q2 2024 Earnings Call Transcript August 1, 2024Blueprint Medicines Corporation beats earnings expectations.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2024 Earnings Call Transcript
Blueprint Medicines Corporation misses on earnings expectations. Reported EPS is $ EPS, expectations were $-1.64.
Insiders Are Dumping These 10 Healthcare Stocks
In this article, we will take a detailed look at Insiders Are Dumping These 10 Healthcare Stocks. For a quick overview of such stocks, read our article Insiders Are Dumping These 5 Healthcare Stocks...
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2023 Earnings Call Transcript
Blueprint Medicines Corporation beats earnings expectations. Reported EPS is $-1.82, expectations were $-2.04.
Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2023 Earnings Call Transcript
Blueprint Medicines Corporation beats earnings expectations. Reported EPS is $-1.82, expectations were $-2.04.
12 Best Genomics Stocks To Buy Now
In this piece, we will take a look at the 12 best genomics stocks to buy now.
Billionaire Hedge Funds
